China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China Jun 25, 2024 21:46 JST Read More
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China Jun 25, 2024 20:00 HKT/SGT Read More
[Media Alert] Are You 'Man' Enough to Embrace Your Inner Health? Jun 25, 2024 16:00 HKT/SGT Read More
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801) Jun 21, 2024 18:30 HKT/SGT Read More
Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day Jun 20, 2024 09:00 HKT/SGT Read More
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China Jun 18, 2024 19:53 JST Read More
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China Jun 18, 2024 18:45 HKT/SGT Read More
ONERHT Foundation's 7th Edition of Annual GAIL Forum Returns on 25 June 2024 at Suntec Singapore Jun 18, 2024 14:30 JST Read More
Former Facebook CEO (ANZ) Stephen Scheeler Announced as Keynote Speaker for Better Outcomes Jun 18, 2024 07:00 HKT/SGT Read More
AlayaCare Residential Launches Financial Management for Retirement Living Jun 17, 2024 07:00 HKT/SGT Read More
Homegrown Robobarista Ella Achieves Highest Daily Record of 400 Cups of Coffee Sold at Sengkang General Hospital, Paving Way for Additional Waves of Expansion in the Healthcare Sector Jun 12, 2024 16:00 HKT/SGT Read More
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India Jun 12, 2024 10:00 HKT/SGT Read More
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in Singapore Jun 10, 2024 15:00 HKT/SGT Read More
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果,进一步展现熊去氧胆小檗碱(HTD1801)的疗效与安全性 Jun 05, 2024 09:00 HKT/SGT Read More
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果,進一步展現熊去氧膽小檁鹼(HTD1801)的療效與安全性 Jun 05, 2024 09:00 HKT/SGT Read More